| 英文別名： |
6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one;PD 0332991;Palbociclib;6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one;6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)-pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one;Flurbiprofen Axetil;OTAVA-BB 1115529;Palbocillib;Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-;PD 0332991 isethionate;DMXBA;GTS21 dihydrochloride;PD-0332991;PD332991;Palbociclib Impurity 26;6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one;Ibrance;PD991;PD0332991;Palbociclib(PD0332991);6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one;G9ZF61LE7G;PD 332991;6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE;6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-y;D10372;HMS3744G13;Z2216894329;BP166224;HMS3265N10;571190-30-2;BRD-K51313569-001-01-1;PD-332991;6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H,8H-pyrido[2,3-d]pyrimidin-7-one;Palbociclib free base;PD 0332991,PD0332991;SB40426;2euf; PD 0332991;L01XE33;8-cyclopentyl-6-acetyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H,8H-pyrido[2,3-d]pyrimidin-7-one;CHEBI:85993;PALBOCICLIB [JAN];BCP9001058;PD 0332991 (Palbociclib);Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)-;Kinome_3823;BCP18381;Palbociclib (JAN/USAN);PALBOCICLIB [WHO-DD];Ibrance (TN);AKOS022205241;6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one;AMY14886;NSC-772256;LQQ;Palbociclib- Bio-X;NSC758247;6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one;BDBM6309;Palbociclib [USAN];A8153;Q15269707;NSC772256;HMS3265M09;EX-A408;[d8]-Palbociclib;s4482;HY-50767;6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-((5-(PIPERAZIN-1-YL)PYRIDIN-2-YL)AMINO(PYRIDO(2,3-D)PYRIMIDIN-7(8H)-ONE;PD 991;PALBOCICLIB [INN];NCGC00263129-08;FT-0697059;CHEMBL189963;6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one;6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-((5-(PIPERAZIN-1-YL)PYRIDIN-2-YL)AMINO)-8H-PYRIDO(2,3-D)PYRIMIDIN-7-ONE;NCGC00263129-22;AHJRHEGDXFFMBM-UHFFFAOYSA-N;6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one;SY026143;MFCD11840850;DTXSID40972590;NCGC00263129-21;571190-30-2 pound not827022-32-2;NSC800815;NSC-758247;SCHEMBL462630;6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[6,5-d]pyrimidin-7-one;PALBOCICLIB [MI];Pyrido-[2,3-d]-pyrimidin-7-one 43;BCPP000125;UNII-G9ZF61LE7G;DB09073;571... |
| 詳細描述： |
博飛美科的帕布昔利布,99%為醫(yī)藥中間體,產(chǎn)品穩(wěn)定,定制速度快,極大地方便了廣大科研客戶的使用需求。產(chǎn)品包裝為1g。查詢關(guān)鍵詞:醫(yī)藥中間體，571190-30-2，帕布昔利布,99%，Palbociclib，博飛美科，Perfemiker，上海，廠家現(xiàn)貨。 |
滬公網(wǎng)安備31011402010658號 
